LIVN
LivaNova PLC Ordinary Shares
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
LivaNova PLC Ordinary Shares (LIVN) Stock: Buy, Sell, or Hold?
$91.14
-1.47 (-1.59%)
▼
5d:
+14.07%
30d:
+17.95%
90d:
+12.82%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect LIVN Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (20%)
Quality Score
42/100
Position
EXTENDED
30-Day Fair Range
$74.96 – $82.21
Position: EXTENDED
Forward P/E & Valuation
19.3x
STRETCHED
vs 15.8x historical avg
Wall Street Target
$105.09
+15.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$78.41 / $99.38
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: LIVN is 10.9% above its trading range ($82.21). Market expects 6.7% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When LIVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$96.96
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$60.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LIVN is currently trading at $91.14, which is considered extended relative to its 30-day fair value range of $74.96 to $82.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.3) compared to its historical average (15.8). At these levels, the market is pricing in 6.7% annual earnings growth.
Technical Outlook: Technically, LIVN is showing sideways momentum. Immediate support is located at $78.41, while resistance sits at $99.38.
Market Sentiment: LIVN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $105.09 (+15.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LIVN is showing sideways momentum. Immediate support is located at $78.41, while resistance sits at $99.38.
Market Sentiment: LIVN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $105.09 (+15.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$74.96 -
$82.21
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
20.0%
Trading Range & Key Levels
30-Day Trading Range
$74.96 -
$82.21
Current vs Trading Range
EXTENDED
Support Level
$78.41
Resistance Level
$99.38
Current Trend
Sideways
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding LIVN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+10.9% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($105.09)
- BULLISH: Expecting earnings turnaround to 6.7% growth with 9.9% revenue growth
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.27
Wall Street Target
$105.09
(+15.3%)
Revenue Growth (YoY)
9.9%
Earnings Growth (YoY)
-78.2%
Profit Margin
13.0%
Valuation Premium vs History
+6.7% premium
PE vs Historical
19.3 vs 15.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.7%
(market-implied from PE analysis)
1-Year Target
$97.25
(+7%)
2-Year Target
$103.76
(+14%)
3-Year Target
$110.71
(+22%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$90.78
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 6.7%)
$113.98
(+25%)
Base:
(SPY PE: 19.3, Growth: 6.7%)
$110.59
(+21%)
Bear:
(PE: 15.8, Growth: 6.7%)
$90.68
(-1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 26.54 | Current EPS (TTM): $3.49
Bull Case
$138.06
(+52%)
Analyst growth 35.5%, PE expands to 29.2
Base Case
$125.51
(+38%)
Market implied 35.5%, PE stable at 26.5
Bear Case
$62.97
(-31%)
Severe decline -20.0%, PE contracts to 22.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share LIVN Analysis
Share this live LIVN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LIVN)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 7, 2026
Daily AI digest
AI Retail Discussion Summary:
LivaNova (LIVN) reported strong Q1 earnings with double-digit organic revenue growth and submission of PMA for OSA therapy to the FDA.
Key Retail Themes:
Robust top-line and EPS growth
Strong performance in Cardiopulmonary and Neuromodulation segments
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:06 AM ET
Data refreshes hourly during market hours. Next update: 6:06 AM
Data refreshes hourly during market hours. Next update: 6:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
Advanced LIVN Option Strategies
Professional options setups generated by AI based on today's LIVN price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LIVN Research Pages
